[CAS NO. 195822-23-2] LQZ-7I
Please click "REQUEST A QUOTE" button if you need other sizes or
custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis,
please:
PRODUCTS SPECIFICATIONS [195822-23-2]
Catalog
SLK-E0108
Brand
Selleck
CAS
195822-23-2
DESCRIPTION [195822-23-2]
Overview
| MDL | MFCD00607076 |
|---|---|
| Molecular Weight | 348.35 |
| Molecular Formula | C₂₀H₁₄F₂N₄ |
| SMILES | FC1=CC=C(NC2=NC3=CC=CC=C3N=C2NC4=CC=C(F)C=C4)C=C1 |
For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
| 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.8707 mL | 14.3534 mL | 28.7068 mL |
| 5 mM | 0.5741 mL | 2.8707 mL | 5.7414 mL |
| 10 mM | 0.2871 mL | 1.4353 mL | 2.8707 mL |
| 50 mM | 0.0574 mL | 0.2871 mL | 0.5741 mL |
Description
LQZ-7I is a novel selectively inhibitor of with IC50s of 4.8 µM and 3.1 µM in prostate cancer cell lines PC-3 and C4-2, respectively. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors.
Powered by Arctom Copyright © 2025 Arctom.
All rights reserved.